So, in this article, I'm going to be presenting you with one of my current, favorite, undervalued pharma plays (there are a few, but this and an alternative that I will also showcase later in the article are my definite favorites). Merck KGaA (Analyst’s Disclosure:I/we have a beneficial long position in the shares of MKGAF, SNY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ...